A functional and proteomics analysis of AKT1(E17K) in human mammary epithelial cells of luminal and myoepithelial cells of origin

被引：0
|
作者：
Salhia, Bodour [1 ]
DuQuette, Rachelle A. [1 ]
Van Cott, Courtney [1 ]
Tegler, Tony [1 ]
Polpitiya, Ashoka [1 ]
Petritis, Konstantinos [1 ]
Carpten, John [1 ]
机构：
[1] TGen, Phoenix, AZ USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-1060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1060
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Functional consequences of cyclin D1 overexpression in human mammary luminal epithelial cells
    Kamalati T.
    Davies D.
    Titley J.
    Crompton M.R.
    Clinical & Experimental Metastasis, 1998, 16 (5) : 415 - 426
  • [22] The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias
    I S Mahmoud
    M A Sughayer
    H A Mohammad
    A A Eshtayeh
    A S Awidi
    M S EL-Khateeb
    S I Ismail
    British Journal of Cancer, 2008, 99 : 488 - 490
  • [23] Mutant AKT1-E17K is oncogenic in lung epithelial cells
    De Marco, Carmela
    Malanga, Donatella
    Rinaldo, Nicola
    De Vita, Fernanda
    Scrima, Marianna
    Lovisa, Sara
    Fabris, Linda
    Carriero, Maria Vincenza
    Franco, Renato
    Rizzuto, Antonia
    Baldassarre, Gustavo
    Viglietto, Giuseppe
    ONCOTARGET, 2015, 6 (37) : 39634 - 39650
  • [24] Absence of E17K mutation in the pleckstrin homology domain of AKT1 in gastrointestinal and liver cancers in the Korean population
    Cao, Zhang
    Song, Jae Hwi
    Kim, Chang Jae
    Cho, Yong Gu
    Kim, Su Young
    Nam, Suk Woo
    Lee, Jung Young
    Park, Won Sang
    APMIS, 2008, 116 (06) : 530 - 533
  • [25] Ubiquitous expression of Akt1 p.(E17K) results in vascular defects and embryonic lethality in mice
    Lindhurst, Marjorie J.
    Li, Wenling
    Laughner, Nathaniel
    Shwetar, Jasmine J.
    Kondolf, Hannah C.
    Ma, Xuefei
    Mukouyama, Yoh-Suke
    Biesecker, Leslie G.
    HUMAN MOLECULAR GENETICS, 2020, 29 (20) : 3350 - 3360
  • [26] The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias
    Mahmoud, I. S.
    Sughayer, M. A.
    Mohammad, H. A.
    Eshtayeh, A. A.
    Awidi, A. S.
    EL-Khateeb, M. S.
    Ismail, S. I.
    BRITISH JOURNAL OF CANCER, 2008, 99 (03) : 488 - 490
  • [27] Durable Clinical Activity to the AKT Inhibitor Ipatasertib in a Heavily Pretreated Patient With an AKT1 E17K Mutant Metastatic Breast Cancer
    Bose, Sminu
    Kalinsky, Kevin
    CLINICAL BREAST CANCER, 2021, 21 (03) : E150 - E153
  • [28] AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K
    Askham, J. M.
    Platt, F.
    Chambers, P. A.
    Snowden, H.
    Taylor, C. F.
    Knowles, M. A.
    ONCOGENE, 2010, 29 (01) : 150 - 155
  • [29] AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K
    J M Askham
    F Platt
    P A Chambers
    H Snowden
    C F Taylor
    M A Knowles
    Oncogene, 2010, 29 : 150 - 155
  • [30] Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations
    Zenz, T.
    Doehner, K.
    Denzel, T.
    Doehner, H.
    Stilgenbauer, S.
    Bullinger, L.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (05) : 742 - 743
12345